Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell Carcinoma

CompletedOBSERVATIONAL
Enrollment

17

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Head and Neck Squamous Cell Carcinoma
Interventions
BIOLOGICAL

the arachidonic acid and EGFR signaling pathways and their interaction in HNSCC tumorigenesis,

patient will undergo transoral pretreatment biopsy of the tumor. A comparable second tumor biopsy will be performed in the office after exactly 5 days of concurrent CRT (5 daily fractions of 180-200 cGy radiotherapy and a single cycle of Cisplatin or Carboplatin/5-FU based chemotherapy).Blood plasma and single-void urine specimens will be collected contemporaneously,before and after 5 days of concurrent CRT.

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00620139 - Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell Carcinoma | Biotech Hunter | Biotech Hunter